Bausch & Lomb Analyst Ratings
Raymond James Initiates Bausch + Lomb at Outperform Rating With $19 Price Target
Bausch & Lomb Analyst Ratings
Evercore ISI Group Maintains In-Line on Bausch & Lomb, Raises Price Target to $15.5
Bausch & Lomb Analyst Ratings
Damo: Bausch & Lomb (BLCO.US) rating was raised from holding and waiting to increase holdings, and the target price was adjusted from $16.00 to $18.00.
Deutsche Bank Adjusts Bausch + Lomb Price Target to $14 From $18, Maintains Hold Rating
HC Wainwright & Co. Reiterates Buy on Bausch & Lomb, Maintains $20 Price Target
Bausch & Lomb Analyst Ratings
Royal Bank of Canada: Maintaining the Bausch & Lomb (BLCO.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $20.00 to $18.00.
Bausch & Lomb Analyst Ratings
RBC Capital Maintains Outperform on Bausch & Lomb, Lowers Price Target to $18
Bausch & Lomb Analyst Ratings
Benchmark Upgrades Emergent Biosolutions to Buy
Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $18
Bausch & Lomb Analyst Ratings
Bausch & Lomb Analyst Ratings
RBC Capital Releases a Buy Rating on Bausch + Lomb Corporation (BLCO)
RBC Lifts Price Target on Bausch + Lomb to $20 From $19 After Better-Than-Expected Q4, Above-Consensus 2024 Revenue Guidance; Outperform Kept
RBC Trims Price Target on Bausch + Lomb to $19 From $20 Ahead of Q4 2023 Report, Keeps Outperform Rating